Cargando…
Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA
BACKGROUND: The advent of prostate specific antigen (PSA) testing in the United States of America (USA) has led to a dramatic increase in the incidence of prostate cancer in the United States as well as the number of men undergoing aggressive treatment with radical prostatectomy and radiation therap...
Autores principales: | Hoffman, Richard M, Stone, S Noell, Espey, David, Potosky, Arnold L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555747/ https://www.ncbi.nlm.nih.gov/pubmed/15755329 http://dx.doi.org/10.1186/1471-2407-5-27 |
Ejemplares similares
-
New Mexico’s Capacity for Increasing the Prevalence of Colorectal Cancer Screening With Screening Colonoscopies
por: Hoffman, Richard M, et al.
Publicado: (2004) -
Colorectal Cancer Incidence and Mortality Disparities in New Mexico
por: Hoffman, Richard M., et al.
Publicado: (2014) -
A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy
por: Marrone, Michael, et al.
Publicado: (2015) -
Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
por: Mori, Rafael Ribeiro, et al.
Publicado: (2020) -
Comparison of health access, lifestyle, prostate cancer knowledge and screening among black men residing in West Africa and the USA
por: Colón, Orlando Rivera, et al.
Publicado: (2021)